Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
4/8
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

10 Years 8 Months

13 Years 8 Months

Fund AUM

₹1387 Cr

₹8636 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.67%

0.79%

Exit Load

0.25%

1%

Benchmark Index

Nifty Pharma TR INR

BSE Healthcare TR INR

No of Holdings

40

37

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(9.38%)
  2. HealthCare Global Enterprises Ltd(5.87%)
  3. Divi's Laboratories Ltd(5.8%)
  4. Abbott India Ltd(5.41%)
  5. Cipla Ltd(5.18%)
  1. Sun Pharmaceuticals Industries Ltd(13.35%)
  2. Lupin Ltd(7.31%)
  3. Dr Reddy's Laboratories Ltd(6.72%)
  4. Cipla Ltd(6.16%)
  5. Divi's Laboratories Ltd(5.8%)
No of Sectors

4

1

Top 3 Sectors
  1. Health(94.26%)
  2. Basic Materials(3.99%)
  3. Consumer Defensive(1.36%)

Health

(100%)

Equity %

99.3%

97.92%

Debt %

-

-

P/E

40.45

36.71

P/B

6.4

5.41

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

6.17%

6.46%

3-Month Return

17.93%

16.52%

6-Month Return

8.77%

10.62%

1-Year Return

9.27%

9.5%

3-Year Return

23.63%

22.56%

5-Year Return

15.03%

13.75%

Sharpe

0.94

0.97

Alpha

-0.31

-0.78

Beta

0.98

0.89

Standard Deviation

16.77

15.23

Information Ratio

-0.18

-0.76

Description

Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Rajat Srivastava

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Most Popular Comparisons